Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1B Pilot Safety Study of LiRIS-TM, A Novel Bladder Drug Delivery Platform in Patients With Interstitial Cystitis

NCT01150565 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT01150565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01150565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1B Pilot Safety Study of LiRIS-TM, A Novel Bladder Drug Delivery Platform in Patients With Interstitial Cystitis
Lead sponsor
Allergan
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2010
Completion date
September 30, 2011
Enrollment
18 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

interstitial cystitis